home / stock / htbx / htbx news


HTBX News and Press, Heat Biologics Inc. From 07/07/21

Stock Information

Company Name: Heat Biologics Inc.
Stock Symbol: HTBX
Market: NASDAQ
Website: heatbio.com

Menu

HTBX HTBX Quote HTBX Short HTBX News HTBX Articles HTBX Message Board
Get HTBX Alerts

News, Short Squeeze, Breakout and More Instantly...

HTBX - Heat Biologics Inc HTBX Technical Analysis

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

HTBX - Heat Biologics added to Russell Microcap Index

At the conclusion of the annual Russell indexes reconstitution, US clinical-stage biopharmaceutical company Heat Biologics (HTBX) will join the Russell Microcap Index.The move is effective June 28, 2021 after the US market opens. Heat Biologics Chief Executive Officer Jeff Wolf ...

HTBX - Heat Biologics Joins Russell Microcap® Index

DURHAM, N.C., June 28, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that it has been added to the Russell Microcap® Index, following...

HTBX - Heat Biologics expands R&D and pre-clinical capabilities

Heat Biologics (HTBX) announces the expansion of its research and development facilities in Morrisville, North Carolina.The expansion will support the addition of enhanced research and development capabilities including in-house synthesis of antibodies and other drugs/reagents as we...

HTBX - Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate Headquarters

DURHAM, N.C., June 23, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidate...

HTBX - VXRT, NOVN, HTBX and CRIS among midday movers

Gainers: Novan (NOVN) +74%.Urban One (UONE) +39%.Iconix Brand (ICON) +28%.Aptinyx (APTX) +24%.Carver Bancorp (CARV) +22%.Vaxart (VXRT) +21%.Xinyuan Real Estate (XIN) +20%Broadway Financial (BYFC) +18%.Amesite (AMST) +18%.Siebert Financial (SIEB) +16%.Losers: Recon Technolo...

HTBX - Novan, Vaxart leads healthcare gainers; Orphazyme, Curis among major losers

Gainers: Novan (NOVN) +81%, Aptinyx (APTX) +25%, Vaxart (VXRT) +39%, Progenity (PROG) +28%, Chemomab Therapeutics (CMMB) +9%.Losers: Orphazyme (ORPH) -41%, Curis (CRIS) -32%, Aptose Biosciences (APTO) -30%, Galecto (GLTO) -22%,&...

HTBX - Vertex Pharmaceuticals, Orange, CureVac among premarket losers' pack

Orphazyme (ORPH) -49% Orphazyme stock losing half its value premarket, after rocketing fourfold the day beforeCVR Energy (CVI) -18%.Curis (CRIS) -13% on updated data for CA-4948 in blood cancers.Galecto (GLTO) -16%.Aptose Biosciences (APTO) -15% presents highlights from EH...

HTBX - Heat Biologics records biggest one-day gain in over four months

Mohammed Haneefa Nizamudeen/iStock via Getty Images Recording its biggest one-day gain since early February, Heat Biologics (HTBX) has reached a near four-month high today. Last week, the company updated Phase 2 data for its off-the-shelf, allogeneic cell therapy HS-110 in combinati...

HTBX - Heat Biologics to Showcase Favorable Survival Data of HS-110 in Previously Treated Non-Small Cell Lung Cancer Patients at 2021 American Society of Clinical Oncology Annual Meeting

DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Dr. Roger B. Cohen, MD, Professor of Medicine at the University ...

Previous 10 Next 10